~~<i id='F205037CA9'><strike id='F205037CA9'><tt id='F205037CA9'><pre id='F205037CA9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：focus 2025-09-30 00:46:50 - browse：19

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

Sponsor introduction

John Arena, SVP, enterprise strategy & solutions, Cencora

Featured speakers

Tara Bannow, hospitals and insurance reporter, STAT
Damian Garde, national biotech reporter, STAT
Matthew Herper, senior writer, medicine; editorial director of events, STAT
Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

leisure time

focus

hotspot

explore

focus

leisure time

JonCherry/GettyImagesTwodaysafterhisrighthandfroze,HartBeznerrealizedforthefirsttimethathemightlosei

WSS

In 'major milestone,' FDA approves first cell therapy for solid tumors

Secretariat’s lessons for human medicine

Merck CEO won’t testify in Senate, citing no expertise in drug prices

A new drug could help frostbite victims avoid its ravages

Weight loss drugs aren’t covered by Obamacare. That may change

Secretariat’s lessons for human medicine

focus

comprehensive

Sponsor introduction

Featured speakers

Sponsored By

leisure time

Heart attack and stroke risk calculators need revising

Abridge raises $150m as clinical notes automation market heats up

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Medical leaders decry Supreme Court decision on affirmative action

Elevance, SCAN deals highlight health insurer acquisition scrutiny

At least 13 dead in Texas as scorching temps continue

Why Medicare shouldn’t cover every FDA

BioMarin wins approval for gene therapy to treat hemophilia A

Ukraine seeks to reclaim its role as a hub for clinical trials

focus

The Affordable Care Act has saved billions in health care costs

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Ukraine seeks to reclaim its role as a hub for clinical trials

Ukraine seeks to reclaim its role as a hub for clinical trials

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

hotspot

explore

focus

leisure time